A Global Biomedical R&D Fund and Mechanism for Innovations of Public Health Importance

article has not abstract

Vyšlo v časopise: A Global Biomedical R&D Fund and Mechanism for Innovations of Public Health Importance. PLoS Med 12(5): e32767. doi:10.1371/journal.pmed.1001831
Kategorie: Essay
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001831

Souhrn

article has not abstract

Zdroje

1. Global strategy and plan of action on public health, innovation and intellectual property. Sixty-first World Health Assembly, 19–24 May 2008, Resolution WHA61.21. Geneva: World Health Organization; 2008

2. Research and development to meet health needs in developing countries: strengthening global financing and coordination. Report of the Consultative Expert Working Group on Research and Development: Financing and Coordination Geneva: World Health Organization; 2012. http://www.who.int/phi/CEWG_Report_5_April_2012.pdf?ua=1

3. Follow-up of the report on the Consultative Expert Working Group on Research and Development: financing and coordination. http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_28Add1-en.pdf

4. Røttingen JA, Chamas C, Goyal LC, Harb H, Lagrada L, Mayosi BM. Securing the public good of health research and development for developing countries. Bull World Health Organ 2012; 90(5):398–400 doi: 10.2471/BLT.12.105460 22589577

5. Commission on Macroeconomics and Health. Macroeconomics and health: investing in health for economic development. Geneva: World Health Organization; 2001 12396642

6. Jamison DT, Summers LH, Alleyne G, Arrow KJ, Berkley S, Binagwaho A, et al. Global health 2035: a world converging within a generation. The Lancet 2013; 382(9908): 1898–955

7. Outterson K. New Business Models for Sustainable Antibiotics. Chatham House, London: Royal Institute of International Affairs; 2014

8. Røttingen JA, Regmi S, Eide M, Young AJ, Viergever RF, Årdal C et al. Mapping available health R&D data: what’s there, what’s missing and what role for a Global Observatory. Lancet 2013; 382(9900):1286–307 doi: 10.1016/S0140-6736(13)61046-6 23697824

9. Grogan K. AMR review head O'Neill calls for $2 billion innovation fund. Pharma times. http://www.pharmatimes.com/Article/15-02-27/AMR_review_head_O_Neill_calls_for_2_billion_innovation_fund.aspx. Accessed 19 March 2015

10. Yamey G, Campe S, Fewer S. Germany, the G7, and global health. BMJ 2015; Mar 5;350:h1210. doi: 10.1136/bmj.h1210 25744556